Xu, L., Pozniak, A., Wildfire, A., Stanfield-Oakley, S. A., Mosier, S. M., Ratcliffe, D., . . . Pillay, D. (2005). Emergence and Evolution of Enfuvirtide Resistance following Long-Term Therapy Involves Heptad Repeat 2 Mutations within gp41. American Society for Microbiology.
Chicago Style aipamenaXu, L., et al. Emergence and Evolution of Enfuvirtide Resistance Following Long-Term Therapy Involves Heptad Repeat 2 Mutations Within Gp41. American Society for Microbiology, 2005.
MLA aipamenaXu, L., et al. Emergence and Evolution of Enfuvirtide Resistance Following Long-Term Therapy Involves Heptad Repeat 2 Mutations Within Gp41. American Society for Microbiology, 2005.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.